课题基金 / 基金详情

项目摘要

项目成果

Mingji Dai的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract The goal of our research program is to innovate the strategy and methodology of organic synthesis and use these innovations to solve problems of biological and medicinal importance and ultimately impact human health. Our program focuses on the synthesis and study of both natural and unnatural molecules with potential for the treatment of cancer, neurological disorders, and drug resistant infectious diseases. We view the completion of a chemical synthesis as the beginning of a larger and deeper scholarly inquiry. It would enable us to profile the biology of the selected natural products and rationally designed small molecules, decipher their mechanism of actions, and optimize the lead compounds into biological probes and novel therapeutics. The selected terpenoid and alkaloid natural products represent both the state-of-the-art challenges for complex molecule synthesis as well as promising lead compounds for novel therapeutic development. Their structural complexity, natural scarcity, and unknown mechanism of actions have significantly hampered their biomedical development. We aim to fill this gap and move these molecules forward in the drug discovery pipeline with a multi-faceted approach centered on innovative chemical synthesis. The expected outcomes of this research will provide (i) new reactions and strategies in the toolbox of both medicinal chemists and synthetic chemists to prepare functional molecules, (ii) a reliable access to the selected target molecules with therapeutic importance, (iii) a collection of medicinally relevant molecules featuring structural novelty, complexity, and diversity for further and larger biological evaluations in academic institutions and pharmaceutical industries, and (iv) novel anticancer, anti-neurodegenerative and antimicrobial lead compounds with potentially novel mode of actions for in vivo and clinical evaluations.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bmc.2020.115678
发表时间: 2020-10-01
期刊: Bioorganic & medicinal chemistry
影响因子: 3.5
作者: [Kyei-Baffour K, Davis DC, Boskovic Z, Kato N, Dai M]
通讯作者: Dai M
DOI: 10.1021/jacs.3c06031
发表时间: 2023-08-30
期刊: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子: 15
作者: [Jiang, Baiyang, Dai, Mingji]
通讯作者: Dai, Mingji
Purdue Drug Discovery Training Program
  • 批准号:
    10186773
  • 项目类别:
  • 资助金额:
    $19.51万
  • 财政年份:
    2019
  • 负责人:
    Mingji Dai
  • 依托单位:
Synthesis and Study of Medicinally Important Molecules
  • 批准号:
    10216307
  • 项目类别:
  • 资助金额:
    $38.18万
  • 财政年份:
    2018
  • 负责人:
    Mingji Dai
  • 依托单位:
Synthesis and Study of Medicinally Important Molecules
  • 批准号:
    10459633
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2018
  • 负责人:
    Mingji Dai
  • 依托单位:
Synthesis and Study of Medicinally Important Molecule
  • 批准号:
    10685687
  • 项目类别:
  • 资助金额:
    $38.18万
  • 财政年份:
    2018
  • 负责人:
    Mingji Dai
  • 依托单位:
海外基金